Effects and molecular mechanisms of Ninghong black tea extract in nonalcoholic fatty liver disease of rats

被引:12
|
作者
Shen, Yu [1 ]
Xiao, Xiaojuan [1 ]
Wu, Kunlu [1 ]
Wang, Yanpeng [1 ]
Yuan, Yijun [1 ]
Liu, Jianwei [1 ]
Sun, Shuming [1 ]
Liu, Jing [1 ]
机构
[1] Cent South Univ, Mol Biol Res Ctr, Sch Life Sci, Changsha 410078, Peoples R China
关键词
microsomal triglyceride transfer protein; Ninghong black tea; nonalcoholic fatty liver disease; peroxisome proliferator-activated receptor alpha; PU-ERH TEA; TRIGLYCERIDE TRANSFER PROTEIN; GREEN TEA; CAFFEINE CONSUMPTION; INFLAMMATORY RESPONSES; INSULIN-RESISTANCE; HEPATIC STEATOSIS; STEATOHEPATITIS; METABOLISM; OBESE;
D O I
10.1111/1750-3841.14846
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The aim of this study is to observe the effects of Ninghong black tea extract on fat deposition and high-fat diet-induced nonalcoholic fatty liver disease (NAFLD) and to explore the potential mechanisms of these effect. Under 2% Ninghong black tea extract diet feeding in rat model, the results showed that Ninghong black tea extract decreased the body fat ratio and the number of lipid droplets in the liver and significantly alleviated NAFLD in the rat model. The real-time fluorescence quantitative polymerase chain reaction results showed that Ninghong black tea extract significantly upregulated the expression of peroxisome proliferator-activated receptor alpha (PPAR alpha), which is important in fatty acid beta-oxidation, and microsomal triglyceride transfer protein (MTP), which plays an important role in the synthesis of very low density lipoprotein (VLDL). By promoting the expression of PPAR alpha and MTP in liver tissue and thereby promoting fatty acid beta-oxidation and VLDL synthesis, Ninghong black tea extract relieves high-fat diet-induced NAFLD.
引用
收藏
页码:800 / 807
页数:8
相关论文
共 50 条
  • [31] Genetics of Alcoholic and Nonalcoholic Fatty Liver Disease
    Anstee, Quentin M.
    Daly, Ann K.
    Day, Christopher P.
    SEMINARS IN LIVER DISEASE, 2011, 31 (02) : 128 - 146
  • [32] Nonalcoholic Fatty Liver Disease and the Gut Microbiome
    Boursier, Jerome
    Diehl, Anna Mae
    CLINICS IN LIVER DISEASE, 2016, 20 (02) : 263 - +
  • [33] Pathogenesis and pathways: nonalcoholic fatty liver disease & alcoholic liver disease
    Robinson, Kyle E.
    Shah, Vijay H.
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 5
  • [34] Contribution of gut microbiota to nonalcoholic fatty liver disease: Pathways of mechanisms
    Bakhshimoghaddam, Farnush
    Alizadeh, Mohammad
    CLINICAL NUTRITION ESPEN, 2021, 44 : 61 - 68
  • [35] Genetics of Nonalcoholic Fatty Liver Disease: An Overview
    Puppala, Jharna
    Siddapuram, Siva Prasad
    Akka, Jyothy
    Munshi, Anjana
    JOURNAL OF GENETICS AND GENOMICS, 2013, 40 (01) : 15 - 22
  • [36] Familial clustering of nonalcoholic fatty liver disease in first-degree relatives of adults with lean nonalcoholic fatty liver disease
    Niltwat, Sorachat
    Limwongse, Chanin
    Charatcharoenwitthaya, Natthinee
    Bunditvorapoom, Duangkamon
    Bandidniyamanon, Wimolrak
    Charatcharoenwitthaya, Phunchai
    LIVER INTERNATIONAL, 2023, 43 (12) : 2713 - 2726
  • [37] Alcoholic liver disease/nonalcoholic fatty liver disease index: distinguishing alcoholic from nonalcoholic fatty liver disease
    Cerovic, Ivana
    Mladenovic, Dusan
    Jesic, Rada
    Naumovic, Tamara
    Brankovic, Milos
    Vucevic, Danijela
    Aleksic, Vuk
    Radosavljevic, Tatjana
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (08) : 899 - 904
  • [38] Protective Effects of Chaihu Shugan San on Nonalcoholic Fatty Liver Disease in Rats with Insulin Resistance
    Jiang Wei-ning
    Li Dan
    Jiang Tao
    Guo Jiao
    Chen Yan-fen
    Wang Jie
    Zhou Yun
    Yang Chao-yan
    Tang Chun-ping
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2018, 24 (02) : 125 - 132
  • [39] Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Takahashi, Yoshihisa
    Sugimoto, Keiichiro
    Inui, Hiroshi
    Fukusato, Toshio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (13) : 3777 - 3785
  • [40] Resveratrol inhibits nonalcoholic fatty liver disease in rats
    Luis Bujanda
    Elizabeth Hijona
    Mikel Larzabal
    Marta Beraza
    Pablo Aldazabal
    Nerea García-Urkia
    Cristina Sarasqueta
    Angel Cosme
    Belen Irastorza
    Alberto González
    Juan I Arenas
    BMC Gastroenterology, 8